AMAG Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss the Results of the Makena PROLONG Trial
29 oct. 2019 07h03 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that NASDAQ has halted trading of the company’s common stock. The U.S. Food and Drug...
AMAG Pharmaceuticals Announces the Publication of the PROLONG Trial Evaluating 17-OHPC in the American Journal of Perinatology
25 oct. 2019 10h19 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the results of PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) were...
AMAG Pharmaceuticals to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Friday, November 1, 2019 at 8:00 a.m. ET
24 oct. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 24, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its third quarter 2019 financial results will be released on Friday, November 1, 2019...
AMAG Pharmaceuticals Announces the Publication of the Phase 3 Vyleesi™ (Bremelanotide Injection) Data in Obstetrics & Gynecology
11 oct. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 11, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that the data from its two pivotal, double-blind placebo-controlled Phase 3 trials (RECONNECT)...
AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP
08 oct. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Oct. 08, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) (“AMAG”) today announced that it has entered into a settlement agreement with Caligan Partners LP...
AMAG Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
25 sept. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Cantor Fitzgerald Global Healthcare Conference in New York on Thursday, October 3,...
AMAG Files Definitive Consent Revocation Statement and Sends Letter to Shareholders
23 sept. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
Details Caligan Partners’ Reckless Business Ideas and Inexperienced Director Nominees Urges Shareholders to Sign and Return AMAG’s GREEN Consent Revocation Card WALTHAM, Mass., Sept. 23, 2019 ...
AMAG Sends Letter to Shareholders
12 sept. 2019 08h00 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 12, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today issued the following letter, which will be mailed to its shareholders. ...
AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
05 sept. 2019 08h41 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Bill...
AMAG Urges Stockholders to Take No Action on Caligan Partners’ Consent Solicitation Materials
04 sept. 2019 17h56 HE
|
AMAG Pharmaceuticals, Inc.
WALTHAM, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today responded to the preliminary consent solicitation filed by Caligan...